Agree. Soon as news comes out about IDE submission volume will start to come in and price will go up. Day/swing traders will jump in riding it up trying to time exit before news of approval/denial comes out. Others will take profits and ride rest out waiting for the same approval/denial news. Others will jump in when IDE approval is announced, then will ride waves into Phase 1 and Phase 2 clinical trials. And then there are the extreme longs who will skim some profits but will still hedge majorly to the P1/P2 phases waiting for the buyout . these are just a few as scenarios imo.
News 
Market Data 
Discover 
